SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001086364-14-000575
Filing Date
2014-01-28
Accepted
2014-01-28 15:23:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 celldex.therapeutics.inc..txt SC 13G/A 11381
  Complete submission text file 0001086364-14-000575.txt   13287
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-37761 | Film No.: 14552626
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 40 EAST 52ND STREET NEW YORK NY 10022
Business Address 40 EAST 52ND STREET NEW YORK NY 10022 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

IRS No.: 320174431 | State of Incorp.: DE | Fiscal Year End: 0226
Type: SC 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies